190 related articles for article (PubMed ID: 24669018)
1. Noncancer health events as a leading cause of competing mortality in advanced head and neck cancer.
Kwon M; Roh JL; Song J; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Ann Oncol; 2014 Jun; 25(6):1208-14. PubMed ID: 24669018
[TBL] [Abstract][Full Text] [Related]
2. Noncancer-Related Health Events and Mortality in Head and Neck Cancer Patients After Definitive Radiotherapy: A Prospective Study.
Kang HS; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Medicine (Baltimore); 2016 May; 95(19):e3403. PubMed ID: 27175640
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for competing non-cancer mortality after definitive treatment for advanced-stage head and neck cancer.
Kim YH; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Oral Dis; 2018 Oct; 24(7):1217-1225. PubMed ID: 29804327
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical significance of cancer cachexia based on time from treatment in advanced-stage head and neck squamous cell carcinoma.
Kwon M; Kim RB; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Head Neck; 2017 Apr; 39(4):716-723. PubMed ID: 28000343
[TBL] [Abstract][Full Text] [Related]
5. Postdiagnostic use of β-blockers and other antihypertensive drugs and the risk of recurrence and mortality in head and neck cancer patients: an observational study of 10,414 person-years of follow-up.
Kim SA; Moon H; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Clin Transl Oncol; 2017 Jul; 19(7):826-833. PubMed ID: 28093700
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database.
Bøje CR; Dalton SO; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
Radiother Oncol; 2014 Jan; 110(1):91-7. PubMed ID: 24412015
[TBL] [Abstract][Full Text] [Related]
7. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma.
Lee DH; Roh JL; Baek S; Jung JH; Choi SH; Nam SY; Kim SY
Otolaryngol Head Neck Surg; 2013 Oct; 149(4):579-86. PubMed ID: 23820107
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for non-cancer health events in patients with head and neck squamous cell carcinoma.
Ryu CH; Roh JL; Kim SB; Lee SW; Choi SH; Nam SY; Kim SY
Ann Oncol; 2013 Apr; 24(4):1049-54. PubMed ID: 23139257
[TBL] [Abstract][Full Text] [Related]
9. Curative-Intent Aggressive Treatment Improves Survival in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma and High Comorbidity Index.
Chen JH; Yen YC; Yang HC; Liu SH; Yuan SP; Wu LL; Lee FP; Lin KC; Lai MT; Wu CC; Chen TM; Chang CL; Chow JM; Ding YF; Wu SY
Medicine (Baltimore); 2016 Apr; 95(14):e3268. PubMed ID: 27057882
[TBL] [Abstract][Full Text] [Related]
10. The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database.
Bøje CR; Dalton SO; Grønborg TK; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
Acta Oncol; 2013 Feb; 52(2):285-93. PubMed ID: 23320773
[TBL] [Abstract][Full Text] [Related]
11. Trends over three decades of the risk of second primary cancer among patients with head and neck cancer.
Jégu J; Binder-Foucard F; Borel C; Velten M
Oral Oncol; 2013 Jan; 49(1):9-14. PubMed ID: 22840787
[TBL] [Abstract][Full Text] [Related]
12. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
[TBL] [Abstract][Full Text] [Related]
13. Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).
Jung YS; Lim J; Jung KW; Ryu J; Won YJ
PLoS One; 2015; 10(7):e0134160. PubMed ID: 26218068
[TBL] [Abstract][Full Text] [Related]
14. Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy.
Argiris A; Brockstein BE; Haraf DJ; Stenson KM; Mittal BB; Kies MS; Rosen FR; Jovanovic B; Vokes EE
Clin Cancer Res; 2004 Mar; 10(6):1956-62. PubMed ID: 15041712
[TBL] [Abstract][Full Text] [Related]
15. Cardiac comorbidity in head and neck cancer patients and its influence on cancer treatment selection and mortality: a prospective cohort study.
Simeoni R; Breitenstein K; Eßer D; Guntinas-Lichius O
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2765-72. PubMed ID: 26581475
[TBL] [Abstract][Full Text] [Related]
16. Predictors of competing mortality in advanced head and neck cancer.
Mell LK; Dignam JJ; Salama JK; Cohen EE; Polite BN; Dandekar V; Bhate AD; Witt ME; Haraf DJ; Mittal BB; Vokes EE; Weichselbaum RR
J Clin Oncol; 2010 Jan; 28(1):15-20. PubMed ID: 19933920
[TBL] [Abstract][Full Text] [Related]
17. Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma.
Singh B; Bhaya M; Zimbler M; Stern J; Roland JT; Rosenfeld RM; Har-El G; Lucente FE
Head Neck; 1998 Jan; 20(1):1-7. PubMed ID: 9464945
[TBL] [Abstract][Full Text] [Related]
18. Risk of second primary cancer in patients with head and neck squamous cell carcinoma: a systemic review and meta-analysis.
Lu D; Zhou X; Sun H; Zeng B; Fu J; Gong J; Liao G; Liang Y; Yang L
Clin Oral Investig; 2023 Sep; 27(9):4897-4910. PubMed ID: 37540282
[TBL] [Abstract][Full Text] [Related]
19. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.
Shen W; Sakamoto N; Yang L
Ann Surg Oncol; 2015 Jan; 22(1):264-71. PubMed ID: 25074664
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with competing mortality among patients with head and neck cancer in Japan.
Takenaka Y; Yasui T; Enomoto K; Miyabe H; Morizane N; Ashida N; Shimizu K; Hirose M; Yamamoto Y; Uno A
Acta Otolaryngol; 2016; 136(3):325-9. PubMed ID: 26634289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
